On September 26, 2022 Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, reported that members of its management team will be presenting at the following upcoming investor conferences in October (Press release, Intellia, SEP 26, 2022, View Source [SID1234621421]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Chardan’s 6th Annual Genetic Medicines Conference, New York
Date: Monday, October 3, 2022
Time: 8:30 a.m. ET
Format: Fireside chat

2022 Truist Securities Genetic Medicine Summit, New York
Genome Editing Panel
Date: Thursday, October 20, 2022
Time: 9:00 a.m. ET
Format: Panel discussion

A live webcast of Intellia’s fireside chat at the Chardan conference will be accessible through the Events and Presentations page of the Investors & Media section of the company’s website at www.intelliatx.com. Replay of the webcast will be available on Intellia’s website for at least 30 days following the presentation.